New grant aims to transform treatment for liver cancer

Currently, there are a few available treatment options for liver cancer, including a combination of immunotherapies and a class of drugs known as tyrosine kinase inhibitors (TKIs), but their long-term effects are limited.

Century Therapeutics buys Clade; Eliem announces $120M PIPE and a deal

Plus, news about Leap Therapeutics, Allay Therapeutics, Harmony Biosciences, Rallybio and CSL Behring: Century Therapeutics acquires Clade: Century is purchasing the off-the-shelf cell therapy startup

April 12, 2024

Breast arterial calcifications on mammograms may indicate higher cardiovascular risk

Heart disease risk assessment tools specific to women remain lacking, despite the fact cardiovascular disease is the leading cause of mortality in women.

September 10, 2024

Students of Shuttered Nursing School Sue State Officials for Overreach

Former students of a now-shuttered for-profit nursing school in Connecticut have filed a federal lawsuit alleging that two state agencies invalidated their course credits, withheld

December 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.